Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence

Completed · Not applicable

Conditions studied: Medication Adherence

In brief

Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospital time. Although OCAs are commonly preferred by patients, adherence to these medications vary. Suboptimal medication adherence leads to loss of treatment efficacy, increased toxicity, and increased health care costs. Thus, it is critical to develop and test interventions that effectively improve adherence to OCAs. Although the medication adherence literature has been criticized for methodological issues, some components of interventions have had promising results on adherence such as electronic monitored adherence feedback, cognitive-education, nurse-based interventions, and technology-based or telehealth strategies. The investigators propose to unify components of these effective approaches in a novel way to assess the efficacy and feasibility of two telehealth-based strategies (electronic medication-event monitoring with feedback and tailored nurse coaching which includes cognitive-education) in an effort increase OCA adherence among cancer patients who are at high-risk for non-adherence in rural eastern North Carolina.

Key facts

Study ID

NCT02543723

Run by

East Carolina University

People needed

128

Starts

2015-11-15

Expected to finish

2020-12-31

Last updated by the study team

2021-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• New cycle or withing the first 3 cycles of OCAs
• Ambulatory
• Age 18 years or older
• Able to consent for self
• Able to read and speak English
• Has a working cellphone or landline.

You may not qualify if…

• Life expectancy <3 months as determined by oncologist
• Current participation in a similar study or in investigational drug trials where adverse effects have not been fully elucidated
• Presence of significant psychiatric or cognitive impairments as determined by oncologists and study teams.

Where it is running

• Vidant Medical Center — Greenville, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.